Get started
Author

J Fleury

High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial
2014 · D Rossille, M Gressier, et al. · Leukemia · 322
Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin’s disease: analysis of 280 patients from the French registry
1997 · P Brice, R Bouabdallah, et al. · Bone Marrow Transplantation · 159
High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: long-term results.
1997 · M Legros, J Dauplat, et al. · Journal of Clinical Oncology · 94
Allogeneic hematopoietic stem cell transplantation in ovarian carcinoma: results of five patients
2002 · J-O Bay, J Fleury, et al. · Bone Marrow Transplantation · 78
Early intensive therapy with autologous stem cell transplantation in advanced Hodgkin’s disease: retrospective analysis of 158 cases from the French registry
1998 · P Moreau, J Fleury, et al. · Bone Marrow Transplantation · 27
rhGM-CSF vs placebo following rhGM-CSF-mobilized PBPC transplantation: a phase III double-blind randomized trial
1997 · M Legros, J Fleury, et al. · Bone Marrow Transplantation · 22
A thrombocytosis occurring in Philadelphia positive CML in molecular response to imatinib can reveal an underlying JAK2V617F myeloproliferative neoplasm
2009 · L. Véronèse, A. Tchirkov, et al. · Leukemia Research · 16
High-dose chemotherapy (HDC) and autologous bone marrow transplant (ABMT) in 39 advanced ovarian cancers: long-term results
1994 · A. Legros, H. Curé, et al. · Cancer Treatment An Update · 8
R‐chop +/‐radiotherapy in Non‐bulky Limited‐stage Diffuse Large B‐cell Lymphoma (dlbcl): Final Results of the Prospective Randomized Phase Iii 02‐03 Trial From the Lysa/goelams
2017 · T. Lamy, G. Damaj, et al. · Hematological Oncology · 6
PDF
Efficacy of a chemotherapy regimen combining Vinorelbine, Epirubicine and Methotrexate (VEM) in locally advanced and metastatic breast cancer
1994 · I. Van Praagh, N. Martineau, et al. · Cancer Treatment An Update · 6
FIRST LINE TREATMENT BY THE RIBVD REGIMEN ELICITS HIGH CLINICAL AND MOLECULAR RESPONSE RATES AND PROLONGED SURVIVAL IN ELDERLY MCL PATIENTS; FINAL RESULTS OF a LYSA GROUP TRIAL
2017 · R. Gressin, N. Daguindau, et al. · Hematological Oncology · 4
PDF
High-dose chemotherapy and autologous stem cell transplantation in advanced epithelial ovarian cancer.
1996 · H Cure, M Legros, et al. · PubMed · 2
507 A phase II study of taxol® (T) (paclitaxel) over 3 hours (H) in 192 platinum pretreated patients (PTS) for ovarian carcinoma (OC)
1995 · C. Lhommé, J.P. Guastalla, et al. · European Journal of Cancer · 1
[Prognostic value of beta-2-microglobulin in Hodgkin disease in young adults].
1994 · J Fleury, J Tortochaux, et al. · PubMed · 1
Long‐term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in elderly mantle cell lymphoma patients. For the LYSA group.
2023 · S. Carras, A. Torroja, et al. · Hematological Oncology
PDF
29 A multicenter study of allogeneic stem cell transplantation (ASCT) for advanced solid tumors
2003 · D.P. Blaise, J. Bay, et al. · Transplantation and Cellular Therapy
PDF
Allogeneic bone marrow transplantation for advanced solid tumors
2000 · D. Blaise, J.O. Bay, et al. · Experimental Hematology
PDF
High-dose chemotherapy and autologous hematopoietic stem cell transplantation for 62 patients with poor prognosis breast cancer
1999 · J. Fleury, D. Béal, et al. · European Journal of Cancer
IL2 in Acute Leukemia
1996 · D. Blaise, A. M. Stoppa, et al. · Hämatologie und Bluttransfusion
Early stages of Hodgkin's disease treated with a decreased dose of radiotherapy: Prognostic value of beta2-microlobulin
1993 · J. Tortochaux, J. Fleury, et al. · European Journal of Cancer
Works count: 20
Citation count: 746
H-index: 8
I10-index: 7
Year
Topic
Type